OFF-LABEL USE OF RITUXIMAB FOR SLE IN EUROPE: A COMPARISON TO PATIENTS TREATED WITH CONVENTIONAL IMMUNOSUPPRESSIVE MEDICATIONS

Author(s):
Vollenhoven, R.F. van; Mild, M.; Dorner, T.; Gremese, E.; Houssiau, F.; Huizinga, T.; Isenberg, D.A.; Kovacs, L.; Ruiz-Irastorza, G.; Squatrito, D.; Emmi, L.; Voskuyl, A.; Mosca, M.; Castro, A.; Iuliano, A.; Inanc, M.; Szucs, G.; Doria, A.; Jacobsen, S.; IRBIS-EMA Study Grp
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2013), Vol. 72, p. 254-254
hdl
1887/103486